Venous thrombosis as a complication of antiemetic treatment

Cancer survivors' needs during various treatment phases after multimodal treatment for colon cancer - is there a role for eHealth?

BMC cancer·2018

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.

Breast cancer research and treatment·2011

A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity.

Annals of oncology : official journal of the European Society for Medical Oncology·2008

[Mucocutaneous manifestations of amyloidosis].

Nederlands tijdschrift voor geneeskunde·2007

Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study.

Annals of oncology : official journal of the European Society for Medical Oncology·2006

Discrepancy between second and first opinion in surgical oncological patients.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2005